iShares Neuroscience and Healthcare ETF
IBRN
3 hedge funds and large institutions have $3.38M invested in iShares Neuroscience and Healthcare ETF in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
4.55% less ownership
Funds ownership: 90.45% → 85.89% (-4.6%)
11% less capital invested
Capital invested by funds: $3.8M → $3.38M (-$419K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$42.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.09M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$87.4K |
IBRN Hedge Fund Activity: Q4 2023 in Review
3 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q4 2023, worth a combined $3.38M — down 11% from $3.8M a quarter earlier.
Fund positioning in IBRN was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $42.9K. The largest seller was BlackRock, cutting an estimated $1.09M.
- 3 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $3.38M of iShares Neuroscience and Healthcare ETF stock for Q4 2023, down 11% quarter-over-quarter.
- 0 funds opened new iShares Neuroscience and Healthcare ETF positions in Q4 2023 and 0 closed out.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q4 2023 was Jane Street, an estimated $42.9K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q4 2023 was BlackRock, an estimated $1.09M sold.
Based on aggregated 13F filings for Q4 2023.